quinoxalines has been researched along with Spinal Cord Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ankeny, DP; Banerjee, R; Garg, SK; Guan, Z; Kigerl, KA; Lai, W; McTigue, DM; Popovich, PG; Wei, P | 1 |
Bell, G; Farag, E; Kalfas, I; Kovaci, B; Kurz, A; Mascha, EJ; Rockwood, E; Sessler, DI; Wang, L | 1 |
1 trial(s) available for quinoxalines and Spinal Cord Diseases
Article | Year |
---|---|
Effects of crystalloid versus colloid and the α-2 agonist brimonidine versus placebo on intraocular pressure during prone spine surgery: a factorial randomized trial.
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Aged; Brimonidine Tartrate; Chemistry, Pharmaceutical; Colloids; Crystalloid Solutions; Female; Humans; Intraocular Pressure; Intraoperative Care; Isotonic Solutions; Male; Middle Aged; Prone Position; Quinoxalines; Spinal Cord Diseases; Treatment Outcome | 2012 |
1 other study(ies) available for quinoxalines and Spinal Cord Diseases
Article | Year |
---|---|
System x(c)(-) regulates microglia and macrophage glutamate excitotoxicity in vivo.
Topics: Animals; Cystine; Disease Models, Animal; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Gene Expression Regulation; Glutamic Acid; Glutathione; Laser Capture Microdissection; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred C57BL; Microglia; Nerve Tissue Proteins; Neurons; Oxidation-Reduction; Quinoxalines; Spinal Cord Diseases | 2012 |